Synergistic Transcutaneous Immunotherapy Enhances Antitumor Immune Responses through Delivery of Checkpoint Inhibitors-Reference-Cited by-同舟云学术

Synergistic Transcutaneous Immunotherapy Enhances Antitumor Immune Responses through Delivery of Checkpoint Inhibitors

Published:2016-09-06 Issue:9 Volume:10 Page:8956-8963
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Ye Yanqi¹²,Wang Jinqiang¹²,Hu Quanyin¹²,Hochu Gabrielle M.¹,Xin Hongliang¹,Wang Chao¹²,Gu Zhen¹²³

Affiliation:

1. Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, North Carolina 27695, United States

2. Molecular Pharmaceutics Division and Center for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

3. Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, United States

Funder

National Center for Advancing Translational Sciences

University of North Carolina

North Carolina Translational and Clinical Sciences, University of North Carolina

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.6b04989

Reference43 articles.